AstraZeneca Plc’s antibody cocktail was only 33% effective at preventing symptomatic Covid-19 in people who had been exposed to the virus, failing a study that was key to the drugmaker’s pandemic push.
CU Anschutz
Fitzsimons Building
13001 East 17th Place
Aurora, CO 80045